-
Innovation Ranking
NewInnovation Ranking – NH Foods Ltd
NH Foods Ltd (NH Foods) is a manufacturer and marketer of food products. The company offers fresh meat and processed meat such as hams and sausages, pre-prepared foods, pork, chicken, and other meat products, retort-packed food, processed marine products and dairy products. NH Foods through Nipponham is involved in farming and breeding of livestocks, such as cattle, hogs, and poultry. The company markets food under Chuka Meisai, Ishigama Kobo and Schau Essen brands. It operates production plants, farms and logistics...
-
Innovation Ranking
NewInnovation Ranking – NH Investment & Securities Co., Ltd.
NH Investment & Securities Co Ltd (NH Investment and Securities), a subsidiary of National Agricultural Cooperative Federation, is a provider of wealth management, investment banking, trading and equity sales business services. It provides individual savings accounts, retirement pension plans, asset management services, stock brokerage and trading services among others. The company services consist of commodity management which includes stocks and bonds, derivatives supply, and equity capital investment. NH Investment and Securities also provides balanced analysis on stocks, bonds, credit, ETFs,...
-
Product Insights
NHS Foundation Trust – Sunderland Eye Hospital – Sunderland
The NHS Foundation Trust – Sunderland Eye Hospital – Sunderland project involves the construction of an 11,148m2, four-story eye care center in Sunderland, the UK. Equip yourself with the essential tools needed to make informed and profitable decisions with our NHS Foundation Trust – Sunderland Eye Hospital – Sunderland report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays....
-
Company Insights
Innovation and Patenting activity of NH Foods Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of NH Foods Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PDS-01ADC in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PDS-01ADC in Non-Small Cell Lung Cancer Drug Details: PDS-0301 (M-9241,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PDS-01ADC in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PDS-01ADC in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: PDS-0301 (M-9241,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PDS-01ADC in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PDS-01ADC in Colorectal Cancer Drug Details: PDS01ADC (PDS0301, M9241 and NHSIL12)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PDS-01ADC in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PDS-01ADC in Solid Tumor Drug Details: PDS-0301 (M-9241, MSB-0010360) (NHS-Interleukin-12) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PDS-01ADC in Small Intestine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Small Intestine Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PDS-01ADC in Small Intestine Cancer Drug Details: PDS01ADC (PDS0301, M9241...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PDS-01ADC in Mesenchymal Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Mesenchymal Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PDS-01ADC in Mesenchymal Tumor Drug Details: PDS-0301 (M-9241, MSB-0010360) (NHS-Interleukin-12) is under...